Annual report pursuant to Section 13 and 15(d)

Shareholders' Equity (Details)

v3.24.1
Shareholders' Equity (Details)
$ / shares in Units, $ in Millions
 12 Months Ended
Apr. 14, 2022
USD ($)
Dec. 31, 2023
USD ($)
vote
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Oct. 28, 2022
shares
Apr. 22, 2022
shares
Sep. 02, 2021
$ / shares
shares
Subsidiary, Sale of Stock [Line Items]            
Common stock authorized (in shares)   500,000,000 500,000,000     500,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001     $ 0.0001
Preferred stock authorized (in shares)   99,874,708 99,874,708     100,000,000
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001     $ 0.0001
Price per share (in dollars per share) | $ / shares   $ 2.85        
Unused capacity | $   $ 21.6        
Units outstanding (in shares)   65,546,174 64,280,631 63,852,690    
Number of votes held | vote   1        
Preferred stock outstanding (in shares)   0 0      
Committed Equity Facility            
Subsidiary, Sale of Stock [Line Items]            
Share purchase period 24 months          
Percentage of share issued 19.99%          
Percentage of share eligible to be purchased based on purchase volume reference amount 50.00%          
Trading day period 10 days          
Percentage of share eligible to be purchased based on shares traded 20.00%          
Sale of stock, number of shares authorized for issuance (in shares)         9,000,000  
Beneficial ownership percentage 4.99%          
Payments of stock issuance costs, settled in shares | $ $ 0.8          
Payments of stock issuance costs, settled in cash | $ $ 0.7          
Shares from transaction (in shares)   497,392        
Aggregate gross proceeds | $   $ 1.2        
Remaining shares available   7,592,939